View Financial HealthPaushak 배당 및 자사주 매입배당 기준 점검 4/6Paushak 수익으로 충분히 충당되는 현재 수익률 0.44% 보유한 배당금 지급 회사입니다. 다음 지급일은 29th August, 2026 이며 배당락일은 다음과 같습니다. 23rd July, 2026.핵심 정보0.4%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률37.3%다음 배당 지급일29 Aug 26배당락일23 Jul 26주당 배당금n/a배당 성향16%최근 배당 및 자사주 매입 업데이트Declared Dividend • Jun 15Dividend of ₹2.50 announcedShareholders will receive a dividend of ₹2.50. Ex-date: 23rd July 2026 Payment date: 29th August 2026 Dividend yield will be 0.5%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (16% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 21% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 1.1% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • Jun 14Paushak Limited announces Annual dividend, payable on August 29, 2026Paushak Limited announced Annual dividend of INR 2.5000 per share payable on August 29, 2026, ex-date on July 23, 2026 and record date on July 23, 2026.Upcoming Dividend • Jul 17Upcoming dividend of ₹20.00 per shareEligible shareholders must have bought the stock before 24 July 2025. Payment date: 30 August 2025. Payout ratio is a comfortable 12% but the company is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.2%). Lower than average of industry peers (0.7%).Declared Dividend • Jun 30Dividend of ₹20.00 announcedDividend of ₹20.00 is the same as last year. Ex-date: 24th July 2025 Payment date: 30th August 2025 Dividend yield will be 0.4%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (12% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 21% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 7.2% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • May 01Paushak Limited Recommends Dividend for the Year Ended March 31, 2025Paushak Limited at its board meeting held on May 1, 2025, recommended a dividend of INR 20 (200%) per Equity Share having face value of INR 10 each for the year ended March 31, 2025, subject To Approve the Shareholders at the upcoming Annual General Meeting (AGM).Upcoming Dividend • Jul 19Upcoming dividend of ₹20.00 per shareEligible shareholders must have bought the stock before 26 July 2024. Payment date: 01 September 2024. Payout ratio is a comfortable 11% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.1%). Lower than average of industry peers (0.7%).모든 업데이트 보기Recent updatesReported Earnings • Jul 04Full year 2026 earnings released: EPS: ₹15.95 (vs ₹20.03 in FY 2025)Full year 2026 results: EPS: ₹15.95 (down from ₹20.03 in FY 2025). Revenue: ₹2.19b (up 3.6% from FY 2025). Net income: ₹393.3m (down 20% from FY 2025). Profit margin: 18% (down from 23% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 13% per year.Declared Dividend • Jun 15Dividend of ₹2.50 announcedShareholders will receive a dividend of ₹2.50. Ex-date: 23rd July 2026 Payment date: 29th August 2026 Dividend yield will be 0.5%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (16% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 21% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 1.1% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • Jun 14Paushak Limited announces Annual dividend, payable on August 29, 2026Paushak Limited announced Annual dividend of INR 2.5000 per share payable on August 29, 2026, ex-date on July 23, 2026 and record date on July 23, 2026.공시 • Jun 13Paushak Limited, Annual General Meeting, Jul 30, 2026Paushak Limited, Annual General Meeting, Jul 30, 2026, at 17:00 Indian Standard Time.공시 • Apr 28Paushak Limited to Report Q4, 2026 Results on May 05, 2026Paushak Limited announced that they will report Q4, 2026 results on May 05, 2026Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹423, the stock trades at a trailing P/E ratio of 28.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 54% over the past three years.New Risk • Mar 23New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹9.20b (US$98.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (17% net profit margin). Market cap is less than US$100m (₹9.20b market cap, or US$98.4m).New Risk • Jan 28New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 18% Last year net profit margin: 27% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.2% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (18% net profit margin).공시 • Jan 19Paushak Limited to Report Q3, 2026 Results on Jan 27, 2026Paushak Limited announced that they will report Q3, 2026 results on Jan 27, 2026Valuation Update With 7 Day Price Move • Nov 14Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹597, the stock trades at a trailing P/E ratio of 32.3x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 44% over the past three years.Reported Earnings • Nov 08Second quarter 2026 earnings released: EPS: ₹27.94 (vs ₹5.76 in 2Q 2025)Second quarter 2026 results: EPS: ₹27.94. Revenue: ₹598.3m (up 4.4% from 2Q 2025). Net income: ₹86.1m (down 39% from 2Q 2025). Profit margin: 14% (down from 25% in 2Q 2025). The decrease in margin was driven by higher expenses.공시 • Oct 31Paushak Limited to Report Q2, 2026 Results on Nov 07, 2025Paushak Limited announced that they will report Q2, 2026 results on Nov 07, 2025Valuation Update With 7 Day Price Move • Oct 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹960, the stock trades at a trailing P/E ratio of 46.3x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 13% over the past three years.New Risk • Oct 03New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 25% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (25% average weekly change). Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (₹2.96b market cap, or US$33.3m).Reported Earnings • Aug 01First quarter 2026 earnings released: EPS: ₹39.04 (vs ₹33.44 in 1Q 2025)First quarter 2026 results: EPS: ₹39.04 (up from ₹33.44 in 1Q 2025). Revenue: ₹577.7m (up 11% from 1Q 2025). Net income: ₹120.3m (up 17% from 1Q 2025). Profit margin: 21% (in line with 1Q 2025). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings.공시 • Jul 23Paushak Limited to Report Q1, 2026 Results on Jul 31, 2025Paushak Limited announced that they will report Q1, 2026 results on Jul 31, 2025Upcoming Dividend • Jul 17Upcoming dividend of ₹20.00 per shareEligible shareholders must have bought the stock before 24 July 2025. Payment date: 30 August 2025. Payout ratio is a comfortable 12% but the company is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.2%). Lower than average of industry peers (0.7%).Valuation Update With 7 Day Price Move • Jul 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹5,656, the stock trades at a trailing P/E ratio of 35.3x. Average trailing P/E is 29x in the Chemicals industry in India. Total loss to shareholders of 39% over the past three years.Reported Earnings • Jul 03Full year 2025 earnings released: EPS: ₹160 (vs ₹176 in FY 2024)Full year 2025 results: EPS: ₹160 (down from ₹176 in FY 2024). Revenue: ₹2.11b (up 2.3% from FY 2024). Net income: ₹493.8m (down 9.2% from FY 2024). Profit margin: 23% (down from 26% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.Declared Dividend • Jun 30Dividend of ₹20.00 announcedDividend of ₹20.00 is the same as last year. Ex-date: 24th July 2025 Payment date: 30th August 2025 Dividend yield will be 0.4%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (12% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 21% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 7.2% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • Jun 30Paushak Limited, Annual General Meeting, Jul 31, 2025Paushak Limited, Annual General Meeting, Jul 31, 2025, at 17:00 Indian Standard Time.Reported Earnings • May 03Full year 2025 earnings released: EPS: ₹160 (vs ₹176 in FY 2024)Full year 2025 results: EPS: ₹160 (down from ₹176 in FY 2024). Revenue: ₹2.25b (up 9.2% from FY 2024). Net income: ₹493.8m (down 9.1% from FY 2024). Profit margin: 22% (down from 26% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings.공시 • May 01Paushak Limited Recommends Dividend for the Year Ended March 31, 2025Paushak Limited at its board meeting held on May 1, 2025, recommended a dividend of INR 20 (200%) per Equity Share having face value of INR 10 each for the year ended March 31, 2025, subject To Approve the Shareholders at the upcoming Annual General Meeting (AGM).공시 • Apr 22Paushak Limited to Report Q4, 2025 Results on May 01, 2025Paushak Limited announced that they will report Q4, 2025 results on May 01, 2025공시 • Apr 03Paushak Limited Announces Resignation of Mr. Abhijit Joshi as Chief Executive OfficerPaushak Limited announced that Mr. Abhijit Joshi (DIN: 06568584), as CEO having superannuated, resigned from the services (including directorship) of the Company, effective from 2nd April, 2025 (after close of business hours). The Board of Directors of the Company place on record their sincere appreciation for the contribution made by Mr. Abhijit Joshi during his association with the Company.공시 • Apr 02Paushak Limited Announces Resignation of Mr. Abhijit Joshi as Whole-Time Director, Effective 2 April 2025Paushak Limited announced that Mr. Abhijit Joshi, Whole-time Director & CEO having superannuated, resigned from the services (including directorship) of the Company, effective from 2 April 2025.Valuation Update With 7 Day Price Move • Mar 26Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₹5,000, the stock trades at a trailing P/E ratio of 26.6x. Average trailing P/E is 24x in the Chemicals industry in India. Total loss to shareholders of 51% over the past three years.공시 • Mar 25Paushak Limited Announces Chief Financial Officer ChangesPaushak Limited informed that Ms. Kirti Shah, CFO has resumed office with effect from 24 March, 2025 (Key Managerial Personnel). In view of the same, Mr. Kaushik Shah, ceases to be Acting CFO (Key Managerial Personnel) of the Company with effect from 24 March, 2025.Reported Earnings • Jan 31Third quarter 2025 earnings released: EPS: ₹49.51 (vs ₹44.21 in 3Q 2024)Third quarter 2025 results: EPS: ₹49.51 (up from ₹44.21 in 3Q 2024). Revenue: ₹555.7m (up 7.3% from 3Q 2024). Net income: ₹152.6m (up 12% from 3Q 2024). Profit margin: 28% (up from 26% in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 22% per year, which means it is significantly lagging earnings.공시 • Jan 22Paushak Limited to Report Q3, 2025 Results on Jan 30, 2025Paushak Limited announced that they will report Q3, 2025 results on Jan 30, 2025Reported Earnings • Oct 30Second quarter 2025 earnings released: EPS: ₹46.09 (vs ₹43.25 in 2Q 2024)Second quarter 2025 results: EPS: ₹46.09 (up from ₹43.25 in 2Q 2024). Revenue: ₹609.7m (up 17% from 2Q 2024). Net income: ₹142.0m (up 6.5% from 2Q 2024). Profit margin: 23% (down from 26% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.공시 • Oct 19Paushak Limited to Report Q2, 2025 Results on Oct 29, 2024Paushak Limited announced that they will report Q2, 2025 results on Oct 29, 2024공시 • Sep 16Paushak Limited Appoints Jain Parkash as Sr. Vice President Operations ExcellencePaushak Limited announced that Mr. Jain Parkash is appointed as Sr. Vice President Operations Excellence, designated as Senior Management Personnel, effective September 16, 2024. Mr. Jain Parkash has done Bachelor's of Engineering (B.E.) in Industrial Engineering with Honours from Thapar University, Patiala. He has about 35 years of rich experience in Specialty Chemicals, Agro-Chemicals & Pharma intermediates. He had been associated with Punjab Chemicals & Crop Protection Limited and Tagros Chemicals India Limited.Board Change • Sep 11Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Tushar Shah was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Aug 06+ 1 more updatePaushak Limited Announces Cessation of Atul Patel as Independent DirectorPaushak Limited announced that Mr. Atul Patel (DIN: 00009587) will be completing his second term of five consecutive years as an Independent Director and consequently shall cease to be Director of the Company with effect from 6th August, 2024 end of the day.공시 • Aug 03Paushak Limited Appoints Tanuj Patel as Independent DirectorPaushak Limited at its Annual General Meeting held on August 2, 2024, approved appointment of Mr. Tanuj Patel as an Independent Director of the Company.공시 • Jul 25Paushak Limited to Report Q1, 2025 Results on Aug 02, 2024Paushak Limited announced that they will report Q1, 2025 results on Aug 02, 2024Upcoming Dividend • Jul 19Upcoming dividend of ₹20.00 per shareEligible shareholders must have bought the stock before 26 July 2024. Payment date: 01 September 2024. Payout ratio is a comfortable 11% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.1%). Lower than average of industry peers (0.7%).Reported Earnings • Jul 06Full year 2024 earnings released: EPS: ₹176 (vs ₹175 in FY 2023)Full year 2024 results: EPS: ₹176 (up from ₹175 in FY 2023). Revenue: ₹2.06b (down 2.9% from FY 2023). Net income: ₹543.5m (flat on FY 2023). Profit margin: 26% (up from 25% in FY 2023). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.공시 • Jun 18Paushak Limited, Annual General Meeting, Aug 02, 2024Paushak Limited, Annual General Meeting, Aug 02, 2024, at 17:00 Indian Standard Time.Declared Dividend • Jun 17Dividend increased to ₹20.00Dividend of ₹20.00 is 14% higher than last year. Ex-date: 26th July 2024 Payment date: 1st September 2024 Dividend yield will be 0.3%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (11% earnings payout ratio) and cash flows (36% cash payout ratio). The dividend has increased by an average of 21% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 7.0% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹6,004, the stock trades at a trailing P/E ratio of 34x. Average trailing P/E is 32x in the Chemicals industry in India. Total loss to shareholders of 12% over the past three years.Reported Earnings • May 04Full year 2024 earnings released: EPS: ₹176 (vs ₹175 in FY 2023)Full year 2024 results: EPS: ₹176 (up from ₹175 in FY 2023). Revenue: ₹2.27b (up 6.8% from FY 2023). Net income: ₹543.5m (flat on FY 2023). Profit margin: 24% (down from 25% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.공시 • Apr 26Paushak Limited to Report Q4, 2024 Results on May 03, 2024Paushak Limited announced that they will report Q4, 2024 results on May 03, 2024Reported Earnings • Feb 04Third quarter 2024 earnings released: EPS: ₹44.21 (vs ₹48.73 in 3Q 2023)Third quarter 2024 results: EPS: ₹44.21 (down from ₹48.73 in 3Q 2023). Revenue: ₹548.7m (down 1.6% from 3Q 2023). Net income: ₹136.3m (down 9.3% from 3Q 2023). Profit margin: 25% (down from 27% in 3Q 2023). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.공시 • Jan 25Paushak Limited to Report Q3, 2024 Results on Feb 02, 2024Paushak Limited announced that they will report Q3, 2024 results on Feb 02, 2024Reported Earnings • Nov 09Second quarter 2024 earnings released: EPS: ₹43.25 (vs ₹42.47 in 2Q 2023)Second quarter 2024 results: EPS: ₹43.25 (up from ₹42.47 in 2Q 2023). Revenue: ₹623.0m (up 25% from 2Q 2023). Net income: ₹133.3m (up 1.8% from 2Q 2023). Profit margin: 21% (down from 26% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 19% per year whereas the company’s share price has increased by 20% per year.공시 • Nov 03Paushak Limited Appoints Chintan Gosaliya as Chief Operating OfficerPaushak Limited announced that Mr. Chintan Gosaliya has joined the Company as Chief Operating Officer and Senior Management Personnel w.e.f. 2nd November, 2023. Mr. Chintan Gosaliya has more than two decades of experience in the Chemicals industry. He has done B. E. Chemical from South Gujarat University & PGEPM from S. P. Jain Institute of Management and Research, Mumbai. Prior to joining the Company, he was associated with Jubilant Ingrevia Limited for about 8 years and was lastly holding the position of Sr. Vice President (Chemicals Intermediate), heading the business segment. He had also worked with Tata Chemicals Limited for about 15 years where he has performed various roles in operations and business development.공시 • Oct 31Paushak Limited to Report Q2, 2024 Results on Nov 08, 2023Paushak Limited announced that they will report Q2, 2024 results on Nov 08, 2023공시 • Aug 03Paushak Limited Approves the Appointment of Tushar Shah as Independent DirectorPaushak Limited at its AGM held on August 1, 2023, approved the appointment of Dr. Tushar Shah as an Independent Director of the company.공시 • Jul 25Paushak Limited to Report Q1, 2024 Results on Aug 01, 2023Paushak Limited announced that they will report Q1, 2024 results on Aug 01, 2023Upcoming Dividend • Jul 18Upcoming dividend of ₹17.50 per share at 0.3% yieldEligible shareholders must have bought the stock before 25 July 2023. Payment date: 31 August 2023. Payout ratio is a comfortable 10.0% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.9%).Reported Earnings • Jul 08Full year 2023 earnings released: EPS: ₹175 (vs ₹122 in FY 2022)Full year 2023 results: EPS: ₹175 (up from ₹122 in FY 2022). Revenue: ₹2.12b (up 42% from FY 2022). Net income: ₹540.1m (up 44% from FY 2022). Profit margin: 25% (in line with FY 2022). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth.공시 • Jun 16Paushak Limited, Annual General Meeting, Aug 01, 2023Paushak Limited, Annual General Meeting, Aug 01, 2023, at 16:00 Indian Standard Time.Reported Earnings • May 07Full year 2023 earnings released: EPS: ₹175 (vs ₹122 in FY 2022)Full year 2023 results: EPS: ₹175 (up from ₹122 in FY 2022). Revenue: ₹2.21b (up 48% from FY 2022). Net income: ₹540.1m (up 44% from FY 2022). Profit margin: 24% (in line with FY 2022). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.공시 • May 05Paushak Limited Recommends Dividend for the Financial Year Ended 31 March 2023The board of directors of Paushak Limited meeting held on May 4, 2023, recommended dividend of INR 17.50/- (175%) per Equity Share having face value of INR 10/- each, subject To Approve the Shareholders at the upcoming Annual General Meeting ('AGM').Valuation Update With 7 Day Price Move • Apr 05Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹7,584, the stock trades at a trailing P/E ratio of 44.2x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 286% over the past three years.Reported Earnings • Jan 28Third quarter 2023 earnings released: EPS: ₹48.73 (vs ₹23.29 in 3Q 2022)Third quarter 2023 results: EPS: ₹48.73 (up from ₹23.29 in 3Q 2022). Revenue: ₹570.0m (up 68% from 3Q 2022). Net income: ₹150.2m (up 109% from 3Q 2022). Profit margin: 26% (up from 21% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 40% per year, which means it is tracking significantly ahead of earnings growth.공시 • Jan 28Paushak Limited Announces Executive Changes, Effective March 31, 2023Paushak Limited announced that at the board meeting held on January 27, 2023, the company approved the resignation of Ms. Manisha Saraf (ICSI Membership No. A20998) as the Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company with effect from 31st March, 2023 (after the closure of business hours) on account of her movement within the group due to internal reorganization. Appointment of Mr. Sagar Gandhi (ICSI Membership No. A44519) as the Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company with effect from 1st April, 2023. (also on account of movement within the group due to internal re-organisation).공시 • Jan 19Paushak Limited to Report Q3, 2023 Results on Jan 27, 2023Paushak Limited announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Jan 27, 2023Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 6 highly experienced directors. Non-Executive Independent Director Atul Patel was the last director to join the board, commencing their role in 2013. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 12Second quarter 2023 earnings released: EPS: ₹42.47 (vs ₹46.33 in 2Q 2022)Second quarter 2023 results: EPS: ₹42.47 (down from ₹46.33 in 2Q 2022). Revenue: ₹544.8m (up 34% from 2Q 2022). Net income: ₹130.9m (down 8.3% from 2Q 2022). Profit margin: 24% (down from 35% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 50% per year, which means it is tracking significantly ahead of earnings growth.공시 • Nov 03Paushak Limited to Report Q2, 2023 Results on Nov 10, 2022Paushak Limited announced that they will report Q2, 2023 results at 3:30 PM, Indian Standard Time on Nov 10, 2022Reported Earnings • Aug 11First quarter 2023 earnings released: EPS: ₹37.47 (vs ₹9.51 in 1Q 2022)First quarter 2023 results: EPS: ₹37.47 (up from ₹9.51 in 1Q 2022). Revenue: ₹510.3m (up 123% from 1Q 2022). Net income: ₹115.5m (up 294% from 1Q 2022). Profit margin: 23% (up from 13% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth.Upcoming Dividend • Jul 25Upcoming dividend of ₹12.00 per shareEligible shareholders must have bought the stock before 01 August 2022. Payment date: 12 August 2022. Payout ratio is a comfortable 9.8% but the company is not cash flow positive. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.7%). Lower than average of industry peers (0.8%).Reported Earnings • Jul 13Full year 2022 earnings released: EPS: ₹122 (vs ₹121 in FY 2021)Full year 2022 results: EPS: ₹122 (up from ₹121 in FY 2021). Revenue: ₹1.50b (up 6.5% from FY 2021). Net income: ₹376.1m (flat on FY 2021). Profit margin: 25% (down from 27% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 55% per year, which means it is well ahead of earnings.공시 • Jul 06Paushak Limited, Annual General Meeting, Aug 09, 2022Paushak Limited, Annual General Meeting, Aug 09, 2022, at 16:00 Indian Standard Time.공시 • Jul 02Paushak Limited Announces Resignation of Shamita Amin as Independent DirectorPaushak Limited announced that Dr. Shamita Amin, Independent Director of the Company has vide her resignation letter dated 30th June, 2022, resigned from the Directorship of the Company effective from the close of business hours on 30th June, 2022, on account of advancing age and indifferent health. Further, Dr. Shamita Amin has confirmed in the resignation letter dated 30th June, 2022 that there are no other material reasons for her resignation.Reported Earnings • May 08Full year 2022 earnings released: EPS: ₹122 (vs ₹121 in FY 2021)Full year 2022 results: EPS: ₹122 (up from ₹121 in FY 2021). Revenue: ₹1.55b (up 10% from FY 2021). Net income: ₹376.1m (flat on FY 2021). Profit margin: 24% (down from 27% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 66% per year, which means it is well ahead of earnings.공시 • May 08Paushak Limited Recommends Dividend for the Year Ended March 31, 2022Paushak Limited announced that at its board meeting held on May 6, 2022, recommended a dividend of INR 12 (120%) per Equity Share having face value of INR 10 each for the year ended March 31, 2022, subject To Approve the Shareholders at the upcoming Annual General Meeting.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 6 highly experienced directors. Non-Executive Independent Director Shamita Amin was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 03Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹23.29 (down from ₹37.44 in 3Q 2021). Revenue: ₹344.1m (down 15% from 3Q 2021). Net income: ₹71.8m (down 38% from 3Q 2021). Profit margin: 21% (down from 29% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 78% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹9,770, the stock trades at a trailing P/E ratio of 75.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 304% over the past three years.Reported Earnings • Nov 03Second quarter 2022 earnings released: EPS ₹46.33 (vs ₹19.84 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹406.3m (up 37% from 2Q 2021). Net income: ₹142.8m (up 134% from 2Q 2021). Profit margin: 35% (up from 21% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 71% per year, which means it is well ahead of earnings.Board Change • Sep 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 4 highly experienced directors. Non-Executive Independent Director Shamita Amin was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.공시 • Jun 02Paushak Limited Announces Temporary Suspension of Manufacturing OperationsPaushak Limited informing about the temporary suspension of company manufacturing operations due to restriction in supply of oxygen for industrial purposes. Company informed that the company has resumed its manufacturing operations as supply of industrial oxygen has been re-stored by the supplier, upon receipt of requisite approvals for the purpose.공시 • May 12Paushak Limited Recommends DividendPaushak Limited announced that at the board meeting held on May 10, 2021, the company recommended a dividend of INR 6.00/- (60%) per Equity Share having face value of INR 10/- each, subject To Approve the Shareholders at the upcoming Annual General Meeting.Reported Earnings • May 11Full year 2021 earnings released: EPS ₹121 (vs ₹113 in FY 2020)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2021 results: Revenue: ₹1.47b (up 6.7% from FY 2020). Net income: ₹373.0m (up 6.8% from FY 2020). Profit margin: 25% (in line with FY 2020). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 67% per year, which means it is tracking significantly ahead of earnings growth.Executive Departure • May 01CEO & Whole-Time Director Abhijit Joshi has left the companyOn the 30th of April, Abhijit Joshi's tenure as CEO & Whole-Time Director of the company ended. We don't have any record of a personal shareholding under Abhijit's name. A total of 2 executives have left over the last 12 months.Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improved over the past weekAfter last week's 39% share price gain to ₹7,334, the stock is trading at a trailing P/E ratio of 69.2x, up from the previous P/E ratio of 49.9x. This compares to an average P/E of 16x in the Chemicals industry in India. Total returns to shareholders over the past three years are 417%.Is New 90 Day High Low • Feb 25New 90-day high: ₹5,877The company is up 72% from its price of ₹3,425 on 27 November 2020. The Indian market is up 17% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.Valuation Update With 7 Day Price Move • Feb 11Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹4,889, the stock is trading at a trailing P/E ratio of 46.1x, up from the previous P/E ratio of 38.2x. This compares to an average P/E of 17x in the Chemicals industry in India. Total returns to shareholders over the past three years are 222%.Is New 90 Day High Low • Feb 09New 90-day high: ₹4,301The company is up 28% from its price of ₹3,365 on 11 November 2020. The Indian market is up 22% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period.Reported Earnings • Jan 30Third quarter 2021 earnings released: EPS ₹37.44 (vs ₹35.75 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: ₹432.4m (up 13% from 3Q 2020). Net income: ₹115.4m (up 4.8% from 3Q 2020). Profit margin: 27% (down from 29% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 45% per year, which means it is tracking significantly ahead of earnings growth.공시 • Jan 21Paushak Limited to Report Q3, 2021 Results on Jan 29, 2021Paushak Limited announced that they will report Q3, 2021 results on Jan 29, 2021Is New 90 Day High Low • Jan 16New 90-day high: ₹3,997The company is up 8.0% from its price of ₹3,694 on 16 October 2020. The Indian market is up 24% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.Is New 90 Day High Low • Nov 01New 90-day low: ₹3,554The company is down 4.0% from its price of ₹3,700 on 03 August 2020. The Indian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.Reported Earnings • Oct 28First half earnings releasedOver the last 12 months the company has reported total profits of ₹321.4m, down 6.7% from the prior year. Total revenue was ₹1.30b over the last 12 months, down 12% from the prior year.공시 • Sep 12Paushak Limited to Report Q1, 2021 Results on Aug 04, 2020Paushak Limited announced that they will report Q1, 2021 results on Aug 04, 2020예정된 배당 지급오늘Jul 10 2026배당락일Jul 23 2026배당 지급일Aug 29 202637 days (배당락일 기준)다음 배당금을 받으려면 앞으로 12 days일 이내에 매수하세요지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 532742 의 주당 배당금은 지난 10 년 동안 안정적이었습니다.배당금 증가: 532742 의 배당금 지급은 지난 10 년 동안 증가했습니다.배당 수익률 vs 시장Paushak 배당 수익률 vs 시장532742의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (532742)0.4%시장 하위 25% (IN)0.3%시장 상위 25% (IN)1.5%업계 평균 (Chemicals)0.8%분석가 예측 (532742) (최대 3년)n/a주목할만한 배당금: 532742 의 배당금( 0.44% )은 Indian 시장에서 배당금 지급자의 하위 25%( 0.29% )보다 높습니다.고배당: 532742 의 배당금( 0.44% )은 Indian 시장에서 배당금 지급자의 상위 25%( 1.47% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 지급 비율 ( 15.7% )이 낮기 때문에 532742 의 배당금 지급은 수익으로 충분히 충당됩니다.주주 현금 배당현금 흐름 범위: 532742 배당금을 지급하고 있지만 회사에는 잉여현금흐름이 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YIN 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/10 10:43종가2026/07/10 00:00수익2026/03/31연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Paushak Limited는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Anil BurraFirstCall Research
Declared Dividend • Jun 15Dividend of ₹2.50 announcedShareholders will receive a dividend of ₹2.50. Ex-date: 23rd July 2026 Payment date: 29th August 2026 Dividend yield will be 0.5%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (16% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 21% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 1.1% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • Jun 14Paushak Limited announces Annual dividend, payable on August 29, 2026Paushak Limited announced Annual dividend of INR 2.5000 per share payable on August 29, 2026, ex-date on July 23, 2026 and record date on July 23, 2026.
Upcoming Dividend • Jul 17Upcoming dividend of ₹20.00 per shareEligible shareholders must have bought the stock before 24 July 2025. Payment date: 30 August 2025. Payout ratio is a comfortable 12% but the company is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.2%). Lower than average of industry peers (0.7%).
Declared Dividend • Jun 30Dividend of ₹20.00 announcedDividend of ₹20.00 is the same as last year. Ex-date: 24th July 2025 Payment date: 30th August 2025 Dividend yield will be 0.4%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (12% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 21% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 7.2% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • May 01Paushak Limited Recommends Dividend for the Year Ended March 31, 2025Paushak Limited at its board meeting held on May 1, 2025, recommended a dividend of INR 20 (200%) per Equity Share having face value of INR 10 each for the year ended March 31, 2025, subject To Approve the Shareholders at the upcoming Annual General Meeting (AGM).
Upcoming Dividend • Jul 19Upcoming dividend of ₹20.00 per shareEligible shareholders must have bought the stock before 26 July 2024. Payment date: 01 September 2024. Payout ratio is a comfortable 11% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.1%). Lower than average of industry peers (0.7%).
Reported Earnings • Jul 04Full year 2026 earnings released: EPS: ₹15.95 (vs ₹20.03 in FY 2025)Full year 2026 results: EPS: ₹15.95 (down from ₹20.03 in FY 2025). Revenue: ₹2.19b (up 3.6% from FY 2025). Net income: ₹393.3m (down 20% from FY 2025). Profit margin: 18% (down from 23% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 13% per year.
Declared Dividend • Jun 15Dividend of ₹2.50 announcedShareholders will receive a dividend of ₹2.50. Ex-date: 23rd July 2026 Payment date: 29th August 2026 Dividend yield will be 0.5%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (16% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 21% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 1.1% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • Jun 14Paushak Limited announces Annual dividend, payable on August 29, 2026Paushak Limited announced Annual dividend of INR 2.5000 per share payable on August 29, 2026, ex-date on July 23, 2026 and record date on July 23, 2026.
공시 • Jun 13Paushak Limited, Annual General Meeting, Jul 30, 2026Paushak Limited, Annual General Meeting, Jul 30, 2026, at 17:00 Indian Standard Time.
공시 • Apr 28Paushak Limited to Report Q4, 2026 Results on May 05, 2026Paushak Limited announced that they will report Q4, 2026 results on May 05, 2026
Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹423, the stock trades at a trailing P/E ratio of 28.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 54% over the past three years.
New Risk • Mar 23New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹9.20b (US$98.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (17% net profit margin). Market cap is less than US$100m (₹9.20b market cap, or US$98.4m).
New Risk • Jan 28New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 18% Last year net profit margin: 27% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.2% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (18% net profit margin).
공시 • Jan 19Paushak Limited to Report Q3, 2026 Results on Jan 27, 2026Paushak Limited announced that they will report Q3, 2026 results on Jan 27, 2026
Valuation Update With 7 Day Price Move • Nov 14Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹597, the stock trades at a trailing P/E ratio of 32.3x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 44% over the past three years.
Reported Earnings • Nov 08Second quarter 2026 earnings released: EPS: ₹27.94 (vs ₹5.76 in 2Q 2025)Second quarter 2026 results: EPS: ₹27.94. Revenue: ₹598.3m (up 4.4% from 2Q 2025). Net income: ₹86.1m (down 39% from 2Q 2025). Profit margin: 14% (down from 25% in 2Q 2025). The decrease in margin was driven by higher expenses.
공시 • Oct 31Paushak Limited to Report Q2, 2026 Results on Nov 07, 2025Paushak Limited announced that they will report Q2, 2026 results on Nov 07, 2025
Valuation Update With 7 Day Price Move • Oct 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹960, the stock trades at a trailing P/E ratio of 46.3x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 13% over the past three years.
New Risk • Oct 03New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 25% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (25% average weekly change). Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (₹2.96b market cap, or US$33.3m).
Reported Earnings • Aug 01First quarter 2026 earnings released: EPS: ₹39.04 (vs ₹33.44 in 1Q 2025)First quarter 2026 results: EPS: ₹39.04 (up from ₹33.44 in 1Q 2025). Revenue: ₹577.7m (up 11% from 1Q 2025). Net income: ₹120.3m (up 17% from 1Q 2025). Profit margin: 21% (in line with 1Q 2025). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings.
공시 • Jul 23Paushak Limited to Report Q1, 2026 Results on Jul 31, 2025Paushak Limited announced that they will report Q1, 2026 results on Jul 31, 2025
Upcoming Dividend • Jul 17Upcoming dividend of ₹20.00 per shareEligible shareholders must have bought the stock before 24 July 2025. Payment date: 30 August 2025. Payout ratio is a comfortable 12% but the company is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.2%). Lower than average of industry peers (0.7%).
Valuation Update With 7 Day Price Move • Jul 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹5,656, the stock trades at a trailing P/E ratio of 35.3x. Average trailing P/E is 29x in the Chemicals industry in India. Total loss to shareholders of 39% over the past three years.
Reported Earnings • Jul 03Full year 2025 earnings released: EPS: ₹160 (vs ₹176 in FY 2024)Full year 2025 results: EPS: ₹160 (down from ₹176 in FY 2024). Revenue: ₹2.11b (up 2.3% from FY 2024). Net income: ₹493.8m (down 9.2% from FY 2024). Profit margin: 23% (down from 26% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.
Declared Dividend • Jun 30Dividend of ₹20.00 announcedDividend of ₹20.00 is the same as last year. Ex-date: 24th July 2025 Payment date: 30th August 2025 Dividend yield will be 0.4%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (12% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 21% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 7.2% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • Jun 30Paushak Limited, Annual General Meeting, Jul 31, 2025Paushak Limited, Annual General Meeting, Jul 31, 2025, at 17:00 Indian Standard Time.
Reported Earnings • May 03Full year 2025 earnings released: EPS: ₹160 (vs ₹176 in FY 2024)Full year 2025 results: EPS: ₹160 (down from ₹176 in FY 2024). Revenue: ₹2.25b (up 9.2% from FY 2024). Net income: ₹493.8m (down 9.1% from FY 2024). Profit margin: 22% (down from 26% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings.
공시 • May 01Paushak Limited Recommends Dividend for the Year Ended March 31, 2025Paushak Limited at its board meeting held on May 1, 2025, recommended a dividend of INR 20 (200%) per Equity Share having face value of INR 10 each for the year ended March 31, 2025, subject To Approve the Shareholders at the upcoming Annual General Meeting (AGM).
공시 • Apr 22Paushak Limited to Report Q4, 2025 Results on May 01, 2025Paushak Limited announced that they will report Q4, 2025 results on May 01, 2025
공시 • Apr 03Paushak Limited Announces Resignation of Mr. Abhijit Joshi as Chief Executive OfficerPaushak Limited announced that Mr. Abhijit Joshi (DIN: 06568584), as CEO having superannuated, resigned from the services (including directorship) of the Company, effective from 2nd April, 2025 (after close of business hours). The Board of Directors of the Company place on record their sincere appreciation for the contribution made by Mr. Abhijit Joshi during his association with the Company.
공시 • Apr 02Paushak Limited Announces Resignation of Mr. Abhijit Joshi as Whole-Time Director, Effective 2 April 2025Paushak Limited announced that Mr. Abhijit Joshi, Whole-time Director & CEO having superannuated, resigned from the services (including directorship) of the Company, effective from 2 April 2025.
Valuation Update With 7 Day Price Move • Mar 26Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₹5,000, the stock trades at a trailing P/E ratio of 26.6x. Average trailing P/E is 24x in the Chemicals industry in India. Total loss to shareholders of 51% over the past three years.
공시 • Mar 25Paushak Limited Announces Chief Financial Officer ChangesPaushak Limited informed that Ms. Kirti Shah, CFO has resumed office with effect from 24 March, 2025 (Key Managerial Personnel). In view of the same, Mr. Kaushik Shah, ceases to be Acting CFO (Key Managerial Personnel) of the Company with effect from 24 March, 2025.
Reported Earnings • Jan 31Third quarter 2025 earnings released: EPS: ₹49.51 (vs ₹44.21 in 3Q 2024)Third quarter 2025 results: EPS: ₹49.51 (up from ₹44.21 in 3Q 2024). Revenue: ₹555.7m (up 7.3% from 3Q 2024). Net income: ₹152.6m (up 12% from 3Q 2024). Profit margin: 28% (up from 26% in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 22% per year, which means it is significantly lagging earnings.
공시 • Jan 22Paushak Limited to Report Q3, 2025 Results on Jan 30, 2025Paushak Limited announced that they will report Q3, 2025 results on Jan 30, 2025
Reported Earnings • Oct 30Second quarter 2025 earnings released: EPS: ₹46.09 (vs ₹43.25 in 2Q 2024)Second quarter 2025 results: EPS: ₹46.09 (up from ₹43.25 in 2Q 2024). Revenue: ₹609.7m (up 17% from 2Q 2024). Net income: ₹142.0m (up 6.5% from 2Q 2024). Profit margin: 23% (down from 26% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.
공시 • Oct 19Paushak Limited to Report Q2, 2025 Results on Oct 29, 2024Paushak Limited announced that they will report Q2, 2025 results on Oct 29, 2024
공시 • Sep 16Paushak Limited Appoints Jain Parkash as Sr. Vice President Operations ExcellencePaushak Limited announced that Mr. Jain Parkash is appointed as Sr. Vice President Operations Excellence, designated as Senior Management Personnel, effective September 16, 2024. Mr. Jain Parkash has done Bachelor's of Engineering (B.E.) in Industrial Engineering with Honours from Thapar University, Patiala. He has about 35 years of rich experience in Specialty Chemicals, Agro-Chemicals & Pharma intermediates. He had been associated with Punjab Chemicals & Crop Protection Limited and Tagros Chemicals India Limited.
Board Change • Sep 11Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Tushar Shah was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Aug 06+ 1 more updatePaushak Limited Announces Cessation of Atul Patel as Independent DirectorPaushak Limited announced that Mr. Atul Patel (DIN: 00009587) will be completing his second term of five consecutive years as an Independent Director and consequently shall cease to be Director of the Company with effect from 6th August, 2024 end of the day.
공시 • Aug 03Paushak Limited Appoints Tanuj Patel as Independent DirectorPaushak Limited at its Annual General Meeting held on August 2, 2024, approved appointment of Mr. Tanuj Patel as an Independent Director of the Company.
공시 • Jul 25Paushak Limited to Report Q1, 2025 Results on Aug 02, 2024Paushak Limited announced that they will report Q1, 2025 results on Aug 02, 2024
Upcoming Dividend • Jul 19Upcoming dividend of ₹20.00 per shareEligible shareholders must have bought the stock before 26 July 2024. Payment date: 01 September 2024. Payout ratio is a comfortable 11% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.1%). Lower than average of industry peers (0.7%).
Reported Earnings • Jul 06Full year 2024 earnings released: EPS: ₹176 (vs ₹175 in FY 2023)Full year 2024 results: EPS: ₹176 (up from ₹175 in FY 2023). Revenue: ₹2.06b (down 2.9% from FY 2023). Net income: ₹543.5m (flat on FY 2023). Profit margin: 26% (up from 25% in FY 2023). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
공시 • Jun 18Paushak Limited, Annual General Meeting, Aug 02, 2024Paushak Limited, Annual General Meeting, Aug 02, 2024, at 17:00 Indian Standard Time.
Declared Dividend • Jun 17Dividend increased to ₹20.00Dividend of ₹20.00 is 14% higher than last year. Ex-date: 26th July 2024 Payment date: 1st September 2024 Dividend yield will be 0.3%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (11% earnings payout ratio) and cash flows (36% cash payout ratio). The dividend has increased by an average of 21% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 7.0% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹6,004, the stock trades at a trailing P/E ratio of 34x. Average trailing P/E is 32x in the Chemicals industry in India. Total loss to shareholders of 12% over the past three years.
Reported Earnings • May 04Full year 2024 earnings released: EPS: ₹176 (vs ₹175 in FY 2023)Full year 2024 results: EPS: ₹176 (up from ₹175 in FY 2023). Revenue: ₹2.27b (up 6.8% from FY 2023). Net income: ₹543.5m (flat on FY 2023). Profit margin: 24% (down from 25% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
공시 • Apr 26Paushak Limited to Report Q4, 2024 Results on May 03, 2024Paushak Limited announced that they will report Q4, 2024 results on May 03, 2024
Reported Earnings • Feb 04Third quarter 2024 earnings released: EPS: ₹44.21 (vs ₹48.73 in 3Q 2023)Third quarter 2024 results: EPS: ₹44.21 (down from ₹48.73 in 3Q 2023). Revenue: ₹548.7m (down 1.6% from 3Q 2023). Net income: ₹136.3m (down 9.3% from 3Q 2023). Profit margin: 25% (down from 27% in 3Q 2023). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
공시 • Jan 25Paushak Limited to Report Q3, 2024 Results on Feb 02, 2024Paushak Limited announced that they will report Q3, 2024 results on Feb 02, 2024
Reported Earnings • Nov 09Second quarter 2024 earnings released: EPS: ₹43.25 (vs ₹42.47 in 2Q 2023)Second quarter 2024 results: EPS: ₹43.25 (up from ₹42.47 in 2Q 2023). Revenue: ₹623.0m (up 25% from 2Q 2023). Net income: ₹133.3m (up 1.8% from 2Q 2023). Profit margin: 21% (down from 26% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 19% per year whereas the company’s share price has increased by 20% per year.
공시 • Nov 03Paushak Limited Appoints Chintan Gosaliya as Chief Operating OfficerPaushak Limited announced that Mr. Chintan Gosaliya has joined the Company as Chief Operating Officer and Senior Management Personnel w.e.f. 2nd November, 2023. Mr. Chintan Gosaliya has more than two decades of experience in the Chemicals industry. He has done B. E. Chemical from South Gujarat University & PGEPM from S. P. Jain Institute of Management and Research, Mumbai. Prior to joining the Company, he was associated with Jubilant Ingrevia Limited for about 8 years and was lastly holding the position of Sr. Vice President (Chemicals Intermediate), heading the business segment. He had also worked with Tata Chemicals Limited for about 15 years where he has performed various roles in operations and business development.
공시 • Oct 31Paushak Limited to Report Q2, 2024 Results on Nov 08, 2023Paushak Limited announced that they will report Q2, 2024 results on Nov 08, 2023
공시 • Aug 03Paushak Limited Approves the Appointment of Tushar Shah as Independent DirectorPaushak Limited at its AGM held on August 1, 2023, approved the appointment of Dr. Tushar Shah as an Independent Director of the company.
공시 • Jul 25Paushak Limited to Report Q1, 2024 Results on Aug 01, 2023Paushak Limited announced that they will report Q1, 2024 results on Aug 01, 2023
Upcoming Dividend • Jul 18Upcoming dividend of ₹17.50 per share at 0.3% yieldEligible shareholders must have bought the stock before 25 July 2023. Payment date: 31 August 2023. Payout ratio is a comfortable 10.0% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.9%).
Reported Earnings • Jul 08Full year 2023 earnings released: EPS: ₹175 (vs ₹122 in FY 2022)Full year 2023 results: EPS: ₹175 (up from ₹122 in FY 2022). Revenue: ₹2.12b (up 42% from FY 2022). Net income: ₹540.1m (up 44% from FY 2022). Profit margin: 25% (in line with FY 2022). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Jun 16Paushak Limited, Annual General Meeting, Aug 01, 2023Paushak Limited, Annual General Meeting, Aug 01, 2023, at 16:00 Indian Standard Time.
Reported Earnings • May 07Full year 2023 earnings released: EPS: ₹175 (vs ₹122 in FY 2022)Full year 2023 results: EPS: ₹175 (up from ₹122 in FY 2022). Revenue: ₹2.21b (up 48% from FY 2022). Net income: ₹540.1m (up 44% from FY 2022). Profit margin: 24% (in line with FY 2022). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
공시 • May 05Paushak Limited Recommends Dividend for the Financial Year Ended 31 March 2023The board of directors of Paushak Limited meeting held on May 4, 2023, recommended dividend of INR 17.50/- (175%) per Equity Share having face value of INR 10/- each, subject To Approve the Shareholders at the upcoming Annual General Meeting ('AGM').
Valuation Update With 7 Day Price Move • Apr 05Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹7,584, the stock trades at a trailing P/E ratio of 44.2x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 286% over the past three years.
Reported Earnings • Jan 28Third quarter 2023 earnings released: EPS: ₹48.73 (vs ₹23.29 in 3Q 2022)Third quarter 2023 results: EPS: ₹48.73 (up from ₹23.29 in 3Q 2022). Revenue: ₹570.0m (up 68% from 3Q 2022). Net income: ₹150.2m (up 109% from 3Q 2022). Profit margin: 26% (up from 21% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 40% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Jan 28Paushak Limited Announces Executive Changes, Effective March 31, 2023Paushak Limited announced that at the board meeting held on January 27, 2023, the company approved the resignation of Ms. Manisha Saraf (ICSI Membership No. A20998) as the Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company with effect from 31st March, 2023 (after the closure of business hours) on account of her movement within the group due to internal reorganization. Appointment of Mr. Sagar Gandhi (ICSI Membership No. A44519) as the Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company with effect from 1st April, 2023. (also on account of movement within the group due to internal re-organisation).
공시 • Jan 19Paushak Limited to Report Q3, 2023 Results on Jan 27, 2023Paushak Limited announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Jan 27, 2023
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 6 highly experienced directors. Non-Executive Independent Director Atul Patel was the last director to join the board, commencing their role in 2013. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 12Second quarter 2023 earnings released: EPS: ₹42.47 (vs ₹46.33 in 2Q 2022)Second quarter 2023 results: EPS: ₹42.47 (down from ₹46.33 in 2Q 2022). Revenue: ₹544.8m (up 34% from 2Q 2022). Net income: ₹130.9m (down 8.3% from 2Q 2022). Profit margin: 24% (down from 35% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 50% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Nov 03Paushak Limited to Report Q2, 2023 Results on Nov 10, 2022Paushak Limited announced that they will report Q2, 2023 results at 3:30 PM, Indian Standard Time on Nov 10, 2022
Reported Earnings • Aug 11First quarter 2023 earnings released: EPS: ₹37.47 (vs ₹9.51 in 1Q 2022)First quarter 2023 results: EPS: ₹37.47 (up from ₹9.51 in 1Q 2022). Revenue: ₹510.3m (up 123% from 1Q 2022). Net income: ₹115.5m (up 294% from 1Q 2022). Profit margin: 23% (up from 13% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth.
Upcoming Dividend • Jul 25Upcoming dividend of ₹12.00 per shareEligible shareholders must have bought the stock before 01 August 2022. Payment date: 12 August 2022. Payout ratio is a comfortable 9.8% but the company is not cash flow positive. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.7%). Lower than average of industry peers (0.8%).
Reported Earnings • Jul 13Full year 2022 earnings released: EPS: ₹122 (vs ₹121 in FY 2021)Full year 2022 results: EPS: ₹122 (up from ₹121 in FY 2021). Revenue: ₹1.50b (up 6.5% from FY 2021). Net income: ₹376.1m (flat on FY 2021). Profit margin: 25% (down from 27% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 55% per year, which means it is well ahead of earnings.
공시 • Jul 06Paushak Limited, Annual General Meeting, Aug 09, 2022Paushak Limited, Annual General Meeting, Aug 09, 2022, at 16:00 Indian Standard Time.
공시 • Jul 02Paushak Limited Announces Resignation of Shamita Amin as Independent DirectorPaushak Limited announced that Dr. Shamita Amin, Independent Director of the Company has vide her resignation letter dated 30th June, 2022, resigned from the Directorship of the Company effective from the close of business hours on 30th June, 2022, on account of advancing age and indifferent health. Further, Dr. Shamita Amin has confirmed in the resignation letter dated 30th June, 2022 that there are no other material reasons for her resignation.
Reported Earnings • May 08Full year 2022 earnings released: EPS: ₹122 (vs ₹121 in FY 2021)Full year 2022 results: EPS: ₹122 (up from ₹121 in FY 2021). Revenue: ₹1.55b (up 10% from FY 2021). Net income: ₹376.1m (flat on FY 2021). Profit margin: 24% (down from 27% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 66% per year, which means it is well ahead of earnings.
공시 • May 08Paushak Limited Recommends Dividend for the Year Ended March 31, 2022Paushak Limited announced that at its board meeting held on May 6, 2022, recommended a dividend of INR 12 (120%) per Equity Share having face value of INR 10 each for the year ended March 31, 2022, subject To Approve the Shareholders at the upcoming Annual General Meeting.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 6 highly experienced directors. Non-Executive Independent Director Shamita Amin was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 03Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹23.29 (down from ₹37.44 in 3Q 2021). Revenue: ₹344.1m (down 15% from 3Q 2021). Net income: ₹71.8m (down 38% from 3Q 2021). Profit margin: 21% (down from 29% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 78% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹9,770, the stock trades at a trailing P/E ratio of 75.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 304% over the past three years.
Reported Earnings • Nov 03Second quarter 2022 earnings released: EPS ₹46.33 (vs ₹19.84 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹406.3m (up 37% from 2Q 2021). Net income: ₹142.8m (up 134% from 2Q 2021). Profit margin: 35% (up from 21% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 71% per year, which means it is well ahead of earnings.
Board Change • Sep 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 4 highly experienced directors. Non-Executive Independent Director Shamita Amin was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
공시 • Jun 02Paushak Limited Announces Temporary Suspension of Manufacturing OperationsPaushak Limited informing about the temporary suspension of company manufacturing operations due to restriction in supply of oxygen for industrial purposes. Company informed that the company has resumed its manufacturing operations as supply of industrial oxygen has been re-stored by the supplier, upon receipt of requisite approvals for the purpose.
공시 • May 12Paushak Limited Recommends DividendPaushak Limited announced that at the board meeting held on May 10, 2021, the company recommended a dividend of INR 6.00/- (60%) per Equity Share having face value of INR 10/- each, subject To Approve the Shareholders at the upcoming Annual General Meeting.
Reported Earnings • May 11Full year 2021 earnings released: EPS ₹121 (vs ₹113 in FY 2020)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2021 results: Revenue: ₹1.47b (up 6.7% from FY 2020). Net income: ₹373.0m (up 6.8% from FY 2020). Profit margin: 25% (in line with FY 2020). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 67% per year, which means it is tracking significantly ahead of earnings growth.
Executive Departure • May 01CEO & Whole-Time Director Abhijit Joshi has left the companyOn the 30th of April, Abhijit Joshi's tenure as CEO & Whole-Time Director of the company ended. We don't have any record of a personal shareholding under Abhijit's name. A total of 2 executives have left over the last 12 months.
Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improved over the past weekAfter last week's 39% share price gain to ₹7,334, the stock is trading at a trailing P/E ratio of 69.2x, up from the previous P/E ratio of 49.9x. This compares to an average P/E of 16x in the Chemicals industry in India. Total returns to shareholders over the past three years are 417%.
Is New 90 Day High Low • Feb 25New 90-day high: ₹5,877The company is up 72% from its price of ₹3,425 on 27 November 2020. The Indian market is up 17% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.
Valuation Update With 7 Day Price Move • Feb 11Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹4,889, the stock is trading at a trailing P/E ratio of 46.1x, up from the previous P/E ratio of 38.2x. This compares to an average P/E of 17x in the Chemicals industry in India. Total returns to shareholders over the past three years are 222%.
Is New 90 Day High Low • Feb 09New 90-day high: ₹4,301The company is up 28% from its price of ₹3,365 on 11 November 2020. The Indian market is up 22% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period.
Reported Earnings • Jan 30Third quarter 2021 earnings released: EPS ₹37.44 (vs ₹35.75 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: ₹432.4m (up 13% from 3Q 2020). Net income: ₹115.4m (up 4.8% from 3Q 2020). Profit margin: 27% (down from 29% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 45% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Jan 21Paushak Limited to Report Q3, 2021 Results on Jan 29, 2021Paushak Limited announced that they will report Q3, 2021 results on Jan 29, 2021
Is New 90 Day High Low • Jan 16New 90-day high: ₹3,997The company is up 8.0% from its price of ₹3,694 on 16 October 2020. The Indian market is up 24% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.
Is New 90 Day High Low • Nov 01New 90-day low: ₹3,554The company is down 4.0% from its price of ₹3,700 on 03 August 2020. The Indian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.
Reported Earnings • Oct 28First half earnings releasedOver the last 12 months the company has reported total profits of ₹321.4m, down 6.7% from the prior year. Total revenue was ₹1.30b over the last 12 months, down 12% from the prior year.
공시 • Sep 12Paushak Limited to Report Q1, 2021 Results on Aug 04, 2020Paushak Limited announced that they will report Q1, 2021 results on Aug 04, 2020